Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit
- PMID: 29158578
- DOI: 10.1038/mp.2017.239
Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit
Abstract
Low doses of ketamine trigger rapid and lasting antidepressant effects after one injection in treatment-resistant patients with major depressive disorder. Modulation of AMPA receptors (AMPARs) in the hippocampus and prefrontal cortex is suggested to mediate the antidepressant action of ketamine and of one of its metabolites (2R,6R)-hydroxynorketamine ((2R,6R)-HNK). We have examined whether ketamine and (2R,6R)-HNK affect glutamatergic transmission and plasticity in the mesolimbic system, brain regions known to have key roles in reward-motivated behaviors, mood and hedonic drive. We found that one day after the injection of a low dose of ketamine, long-term potentiation (LTP) in the nucleus accumbens (NAc) was impaired. Loss of LTP was maintained for 7 days and was not associated with an altered basal synaptic transmission mediated by AMPARs and N-methyl-D-aspartate receptors (NMDARs). Inhibition of mammalian target of rapamycin signaling with rapamycin did not prevent the ketamine-induced loss of LTP but inhibited LTP in saline-treated mice. However, ketamine blunted the increase in the phosphorylation of the GluA1 subunit of AMPARs at a calcium/calmodulin-dependent protein kinase II/protein kinase C site induced by an LTP induction protocol. Moreover, ketamine caused a persistent increased phosphorylation of GluA1 at a protein kinase A site. (2R,6R)-HNK also impaired LTP in the NAc. In dopaminergic neurons of the ventral tegmental area from ketamine- or (2R,6R)-HNK-treated mice, AMPAR-mediated responses were depressed, while those mediated by NMDARs were unaltered, which resulted in a reduced AMPA/NMDA ratio, a measure of long-term synaptic depression. These results demonstrate that a single injection of ketamine or (2R,6R)-HNK induces enduring alterations in the function of AMPARs and synaptic plasticity in brain regions involved in reward-related behaviors.
Similar articles
-
Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine.Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):297-302. doi: 10.1073/pnas.1814709116. Epub 2018 Dec 17. Proc Natl Acad Sci U S A. 2019. PMID: 30559184 Free PMC article.
-
Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function.Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):5160-5169. doi: 10.1073/pnas.1816071116. Epub 2019 Feb 22. Proc Natl Acad Sci U S A. 2019. PMID: 30796190 Free PMC article.
-
Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine.Neuropharmacology. 2019 Jul 15;153:73-81. doi: 10.1016/j.neuropharm.2019.04.019. Epub 2019 Apr 20. Neuropharmacology. 2019. PMID: 31015046
-
Mechanisms of ketamine action as an antidepressant.Mol Psychiatry. 2018 Apr;23(4):801-811. doi: 10.1038/mp.2017.255. Epub 2018 Mar 13. Mol Psychiatry. 2018. PMID: 29532791 Free PMC article. Review.
-
Synaptic mechanisms underlying rapid antidepressant action of ketamine.Am J Psychiatry. 2012 Nov;169(11):1150-6. doi: 10.1176/appi.ajp.2012.12040531. Am J Psychiatry. 2012. PMID: 23534055 Review.
Cited by
-
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment.Neuropharmacology. 2023 Mar 15;226:109422. doi: 10.1016/j.neuropharm.2023.109422. Epub 2023 Jan 13. Neuropharmacology. 2023. PMID: 36646310 Free PMC article. Review.
-
(2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions.Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6441-6450. doi: 10.1073/pnas.1819540116. Epub 2019 Mar 13. Proc Natl Acad Sci U S A. 2019. PMID: 30867285 Free PMC article.
-
Decoding the Mechanism of Action of Rapid-Acting Antidepressant Treatment Strategies: Does Gender Matter?Int J Mol Sci. 2019 Feb 22;20(4):949. doi: 10.3390/ijms20040949. Int J Mol Sci. 2019. PMID: 30813226 Free PMC article. Review.
-
Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel Therapeutics.Adv Neurobiol. 2023;30:287-297. doi: 10.1007/978-3-031-21054-9_12. Adv Neurobiol. 2023. PMID: 36928855
-
A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders.J Eat Disord. 2022 May 6;10(1):65. doi: 10.1186/s40337-022-00588-9. J Eat Disord. 2022. PMID: 35524316 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources